Type of Posting: General Announcement
Posting Date: 30–Sep–2022
This Notice provides an update regarding the proposed Interim Revision Announcement (IRA) to the Enoxaparin Sodium monograph in Pharmacoepial Forum 48(3). The Biologics Monographs 3 – Complex Biologics and Vaccines (BIO3) Expert Committee reviewed the public comments received from stakeholders and established an official date of December 1, 2023 to provide additional time for compliance. The IRA is scheduled to publish on November 18, 2022.
Per General Notices and Requirements, Section 3.10 Applicability of Standards, early adoption of revised standards in advance of the official date is allowed by USP unless specified otherwise at the time of publication. Users may begin using the revised method prior to the official date.
Should you have any questions, please contact Julie Zhang, Team Lead (301-816-8350 or email@example.com).